Category: Pharmaceuticals
United States Pharmaceuticals
-
U.S. Tardive Dyskinesia Treatment Market - 2024 - 2031
... Tardive dyskinesia (TD) is a neurological disease noted by involuntary, repetitive movements. The disease often results from long-term use of certain medications, particularly antipsychotics, prescribed for psychiatric conditions like schizophrenia and bipolar disorder. Symptoms include ... Read More
-
Health, Beauty & Personal Care Stores - 2025 US Industry Market Research Report with Updated Analysis & Forecasts
... covering 2016-2029. This Kentley Insights report includes historical and forecasted market size, ecommerce, product lines, inventory turns, gross margin, profitability, financial ratios, BCG matrix, statistics by state, operating expense details, organizational composition, consolidation analysis, employee ... Read More
-
Nutrition Supplement Stores - 2025 US Industry Market Research Report with Updated Analysis & Forecasts
... Kentley Insights report includes historical and forecasted market size, ecommerce, product lines, inventory turns, gross margin, profitability, financial ratios, BCG matrix, statistics by state, operating expense details, organizational composition, consolidation analysis, employee productivity, price inflation, ... Read More
-
Other Health & Personal Care Stores - 2025 US Industry Market Research Report with Updated Analysis & Forecasts
... covering 2016-2029. This Kentley Insights report includes historical and forecasted market size, ecommerce, product lines, inventory turns, gross margin, profitability, financial ratios, BCG matrix, statistics by state, operating expense details, organizational composition, consolidation analysis, employee ... Read More
-
Clinical Trials Market in US 2025-2029
... the clinical trials market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Cycling Power Meters
... at a CAGR of 4.4% over the analysis period 2024-2030. Crank Arm-Based Power Meters, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$197.5 Million by the ... Read More
-
Clinical Rollators
... CAGR of 5.0% over the analysis period 2024-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of the analysis ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Cognitive Computing
... CAGR of 27.6% over the analysis period 2024-2030. Natural Language Processing Technology, one of the segments analyzed in the report, is expected to record a 25.1% CAGR and reach US$159.0 Billion by the end of ... Read More
-
Coronary Artery Bypass Grafts (CABG)
... Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million ... Read More
-
Internet Ad Spending
... at a CAGR of 7.8% over the analysis period 2024-2030. Search Advertising, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$214.9 Billion by the end of ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Hydroponics
... 14.2% over the analysis period 2024-2030. Tomatoes Crop, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth ... Read More
-
Krill Oil
... CAGR of 10.1% over the analysis period 2024-2030. Krill Oil Softgels, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$485.1 Million by the end of the ... Read More
-
Pectin
... 5.0% over the analysis period 2024-2030. Food & BeverageEnd-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$904.0 Million by the end of the analysis period. ... Read More
-
Counter Terror and Public Safety Technology
... reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Cyber Security Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and ... Read More
-
Healthcare Cleanroom Consumables
... at a CAGR of 4.8% over the analysis period 2024-2030. Cleanroom Apparel, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the end of ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Urgent Care Center
... at a CAGR of 6.0% over the analysis period 2024-2030. Trauma / Injury Treatment Service, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$12.2 Billion by ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Books
... 2.9% over the analysis period 2024-2030. Mystery Books, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$35.4 Billion by the end of the analysis period. Growth ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More
Research Assistance
